COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 2022: Articles 20211-20220  | Next

Impact of COVID-19: Decrease in the Number of Fledging Barn Swallow Chicks in Tokyo
Hayashi, T., Yaegashi, N., Konishi, I.
10.1101/2020.11.16.380899 — Posted: 2020-11-17
The effects of hypertension as an existing comorbidity on mortality rate in patients with COVID-19: a systematic review and meta-analysis.
Whiteman, E.
10.1101/2020.11.16.20149377 — Posted: 2020-11-17
Immunogenicity of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
Solforosi, L., Kuipers, H., Rosendahl Huber, S. K., van der Lubbe, J. E. M., Dekking, L., Czapska-Casey, D. N., Izquierdo Gil, A., Baert, M., Drijver, J., Vaneman, J., van Huizen, E., Choi, Y., Vreugdenhil, J., Dalebout, T. J., Myeni, S. K., Kikkert, M., Snijder, E. J., Barouch, D. H., Koopman, G., Mooij, P., Bogers, W. M. J. M., Muchene, L., Tolboom, J. T. B. M., Roozendaal, R., Schuitemaker, H., Wegmann, F., Zahn, R. C.
10.1101/2020.11.17.368258 — Posted: 2020-11-17
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2
Ye, G., Gallant, J., Massey, C., Shi, K., Tai, W., Zheng, J., Odle, A., Vickers, M., Shang, J., Wan, Y., Drelich, A., Kempaiah, K., Tat, V., Perlman, S., Du, L., Tseng, C.-T., Aihara, H., LeBeau, A., Li, F.
10.1101/2020.11.17.386532 — Posted: 2020-11-17
The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2
Li, P., Guo, R., Liu, Y., Zhang, Y., Hu, J., Ou, X., Mi, D., Zhang, L., wang, x., Wu, Z., Wang, J., Jin, Q., Qian, Z.
10.1101/2020.11.16.385849 — Posted: 2020-11-17
A continuously self-sterilizing form of copper capable of 99% SARS-CoV-2 deactivation in 30 seconds.
Zinn, A. A., Izadjoo, M., Kim, H., Kehn-Hall, K., Lehman, C., Brody, R. L., Roth, R. R., Vega, A., Nguyen, K. K., Ngo, N. T., Zinn, H. T., Panny, L., Flor, R., Antonopoulos, N., Stoltenberg, R. M.
10.1101/2020.11.16.384040 — Posted: 2020-11-17
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19
Rappazzo, C. G., Tse, L. V., Kaku, C. I., Wrapp, D., Sakharkar, M., Huang, D., Deveau, L. M., Yockachonis, T. J., Herbert, A. S., Battles, M. B., O'Brien, C. M., Brown, M. E., Geoghegan, J. C., Belk, J., Peng, L., Yang, L., Scobey, T. D., Burton, D. R., Nemazee, D., Dye, J. M., Voss, J. E., Gunn, B. M., McLellan, J. S., Baric, R. S., Gralinski, L. E., Walker, L. M.
10.1101/2020.11.17.385500 — Posted: 2020-11-17
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
Sokal, A., Chappert, P., Roeser, A., Barba-Spaeth, G., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Bouvier-Alias, M., Crickx, E., Beldi Ferchiou, A., Hue, S., Languille, L., Baloul, S., Noizat-Pirenne, F., Luka, M., Megret, J., Menager, M., Pawlotsky, J.-M., Fillatreau, S., Rey, F. A., Weill, J.-C., Reynaud, C.-A., Mahevas, M.
10.1101/2020.11.17.385252 — Posted: 2020-11-17
Assessment of protein-protein interfaces in cryo-EM derived assemblies
Malhotra, S., Joseph, A. P., Thiyagalingam, J., Topf, M.
10.1101/2020.11.17.387068 — Posted: 2020-11-17
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Touret, F., Driouich, J.-S., Cochin, M., Petit, P. R., Gilles, M., Barthelemy, K., Moureau, G., Malvy, D., Solas, C., de Lamballerie, X., Nougairede, A.
10.1101/2020.11.17.386904 — Posted: 2020-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).